This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Edit Alattyani: Innovator in Pharmaceutical Chemistry
Introduction
Edit Alattyani is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative methods in drug preparation. Her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Edit Alattyani holds a patent for a method of preparing phenyloxymethyl-nitro-imidazole derivatives. This patent, which includes the preparation of Fexinidazole, outlines a detailed process that involves several key steps. The method includes reacting 1-methyl-2-hydroxymethyl-5-nitro-imidazole with methanesulfonyl chloride, followed by the addition of a solution of 4-methyl-mercapto-phenol. The final steps involve separating Fexinidazole from the reaction mixture and purifying the compound.
Career Highlights
Edit Alattyani is currently employed at Sanofi, a leading global healthcare company. Her role at Sanofi allows her to apply her expertise in pharmaceutical development and contribute to innovative solutions in medicine.
Collaborations
Edit has collaborated with notable colleagues, including Zsolt Párkányi and Zoltan Bugir. These collaborations have fostered a productive environment for research and development in their field.
Conclusion
Edit Alattyani's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. Her patent for Fexinidazole showcases her dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile